Last reviewed · How we verify
Globulin, Immune
Globulin, Immune is a Small molecule drug developed by American National Red Cross. It is currently FDA-approved.
At a glance
| Generic name | Globulin, Immune |
|---|---|
| Sponsor | American National Red Cross |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase 1 Study of IM-1021 in Participants With Advanced Cancer (PHASE1)
- Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer (PHASE2)
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial (PHASE2)
- Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy (PHASE3)
- Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (PHASE3)
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma (PHASE3)
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (PHASE3)
- Descartes-08 for Patients With Systemic Lupus Erythematosus (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Globulin, Immune CI brief — competitive landscape report
- Globulin, Immune updates RSS · CI watch RSS
- American National Red Cross portfolio CI
Frequently asked questions about Globulin, Immune
What is Globulin, Immune?
Globulin, Immune is a Small molecule drug developed by American National Red Cross.
Who makes Globulin, Immune?
Globulin, Immune is developed and marketed by American National Red Cross (see full American National Red Cross pipeline at /company/american-national-red-cross).
What development phase is Globulin, Immune in?
Globulin, Immune is FDA-approved (marketed).
Related
- Manufacturer: American National Red Cross — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing